10 m .1.

Transdermal Drug Delivery System (TDDS) – Definition & Factors Affecting Permeation
Definition of TDDSA Transdermal Drug Delivery System (TDDS) is a method of administering drugs
through theskin to achieve systemic effects. It involves the application of a drug formulation (such as
patches, gels, or creams) that allows the drug to pass through the skin layers and enter the
bloodstream. This method ensures controlled, sustained drug release, improving therapeutic
effectiveness and patient [Link] Affecting Permeation Through the Skin
Several factors influence drug permeation in TDDS, which can be classified into four main
categories:1. Physiological Factors (Skin-related factors)2. Drug-related Factors3. Formulation Factors
4. Application FactorsLet’s explore each of these in detail:1. Physiological Factors (Skin-related
Factors) The skin is the primary barrier to drug absorption. The efficiency of drug permeation
depends on:(a) Skin StructureThe skin consists of three main layers:• Epidermis (Outer Layer): The
stratum corneum (outermost part) is the main barrierto drug absorption. It is made up of keratinized
dead cells arranged in a "brick-andmortar" structure. Only small, lipophilic molecules can pass
through easily. • Dermis (Middle Layer): Contains blood vessels, which help transport the drug into
systemic circulation.• Hypodermis (Deep Layer): Composed of fat tissues that can act as a reservoir
for lipophilic drugs.(b) Skin Hydration• Hydrated skin is more permeable than dry skin.
• Water disrupts the tightly packed lipids in the stratum corneum, making it easier for
drugs to pass through.• Occlusive dressings (e.g., plastic films, petroleum jelly) increase hydration
andenhance drug absorption.(c) Skin Thickness• Thin skin (e.g., behind the ear, inner forearm)
absorbs drugs more efficiently.• Thick skin (e.g., palms, soles of feet) has a stronger barrier and
absorbs drugs slowly.(d) Blood Flow• Higher blood circulation increases drug absorption and
transport. • Areas with high blood flow (e.g., scalp, abdomen) show better drug uptake
compared to areas with poor circulation.(e) Age and Skin Condition• Young skin has higher
permeability than aged skin.• Damaged or diseased skin (e.g., eczema, burns) allows faster drug
penetration.2. Drug-Related FactorsThe physical and chemical properties of the drug play a major
role in its ability to penetratethe skin.(a) Molecular Size• Small molecules (< 500 Da) diffuse through
the skin more easily.• Large molecules struggle to pass through the compact structure of the stratum
corneum.(b) Lipophilicity (Fat-Solubility)• The skin is lipid-rich, so lipophilic (fat-soluble) drugs
permeate more easily.• Highly lipophilic drugs may stay in the skin layers instead of reaching the
bloodstream.• Ideal drugs have balanced lipophilicity (log P ~1-3) for optimal absorption.
(c) Drug Concentration• A higher concentration of the drug in the formulation increases the driving
force fordiffusion.(d) Ionization and pH• Non-ionized (neutral) drugs are more permeable than
ionized drugs, which facedifficulty crossing the lipophilic skin barrier.• The drug's pH must be close to
skin pH (~5.5) for effective absorption.3. Formulation FactorsThe composition of the drug
formulation determines how well it interacts with the skin.(a) Drug Solubility• The drug must be
soluble in both lipophilic (skin) and hydrophilic (blood)environments for effective absorption.(b)
Penetration Enhancers• These are agents added to formulations to temporarily alter the stratum
corneum and improve drug absorption.• Types of penetration enhancers:1. Chemical Enhancers:
▪ Ethanol, DMSO (Dimethyl Sulfoxide), Oleic Acid, Propylene Glycol.▪ Work by disrupting the lipid
structure of the stratum corneum.2. Physical Methods:▪ Microneedles: Create microchannels for
direct drug entry.▪ Iontophoresis: Uses a mild electric current to drive charged drugs through the
skin.▪ Sonophoresis: Uses ultrasound waves to enhance permeability.(c) Polymer Matrix in Patches
• In transdermal patches, polymers regulate the drug release rate to maintain steady
absorption.4. Application FactorsHow and where the drug is applied affects its absorption efficiency .
(a) Site of Application• Different body regions have different permeability due to variations in skin
thickness,hydration, and blood flow.

..
10 m 2 Introduction to GRDDSGastroretentive Drug Delivery Systems (GRDDS) are designed to
prolong drug retention inthe stomach, ensuring sustained drug release and improved bioavailability
for drugs that:• Have a narrow absorption window in the stomach or upper intestine.• Are unstable
or poorly soluble in intestinal pH (alkaline environment).• Are used for localized treatment in the
stomach (e.g., Helicobacter pylori infection,peptic ulcers).Classification of GRDDSGastroretentive
systems are classified into the following major types:1. Floating Drug Delivery Systems (FDDS)2.
Swelling and Expanding Systems3. Mucoadhesive (Bioadhesive) Systems4. High-Density Systems
5. Magnetic Systems 6. Raft-Forming SystemsLet’s explore each of these systems in detail:1. Floating
Drug Delivery Systems (FDDS)These systems are designed to remain buoyant in gastric fluids for
prolonged [Link] ensures the drug remains in the stomach, allowing gradual release before
moving to the [Link] of Floating Systems:(a) Effervescent Floating Systems• These systems
contain gas-generating agents (e.g., sodium bicarbonate, citric acid,tartaric acid) that release carbon
dioxide (CO₂) in the presence of gastric fluid.• The CO₂ forms bubbles that reduce the density of the
dosage form, making it [Link]:• Floating tablets/capsules• Floating beads/microspheres
(b) Non-Effervescent Floating Systems• These systems rely on hydrophilic polymers (e.g.,
hydroxypropyl methylcellulose(HPMC), chitosan, alginate) that absorb water, swell, and become less
dense thangastric fluids, allowing them to float. Examples:• Hydrodynamically balanced systems
2. Swelling and Expanding Systems• These systems absorb gastric fluids and swell, increasing in size
and preventing passage through the pyloric sphincter.• Retained in the stomach due to their larger
size.• After drug release, they shrink and are [Link]:• Expandable tablets and capsules
3. Mucoadhesive (Bioadhesive) Systems• These systems use bioadhesive polymers (e.g., carbopol,
chitosan, alginate, pectin,gelatin) to bind to the gastric mucosa, keeping the drug in the stomach.
• Helps in sustained release and localized [Link]:• Mucoadhesive microspheres
GRDDS Type Mechanism Leakey material used Application
Floating system s Buoyancy (lower Sodium bicarbonate, Drugs with narrow
density than gastric HPMC, alginate absorption window
fluid
Swelling and expanding Absorbs water and Hydrogels, Controlled drug
expands superabsorbent release
polymers
Mucoadhesive Binds to gastric Chitosan, carbopol, Local stomach
mucosa alginate treatment
High-Density Settles in the stomach Barium sulfate, zinc Drugs that require
(higher density) oxide prolonged stomach
retention
Magnetic Controlled by external Iron oxide, magnetic Experimental
magnetic field nanoparticles applications
Raft-Forming Forms a floating gel Alginate, pectin GERD and acid reflux
layer treatment
Applications:• Suitable for anti-ulcer drugs (e.g., sucralfate).• Used for treating Helicobacter pylori
infections in the stomach.4. High-Density Systems (Sedimentation-Based Systems)• These
formulations are denser than gastric fluids (>2.5 g/cm³), causing them to sink and stay in the stomach
instead of passing into the intestines.• Contain high-density materials like barium sulfate, zinc oxide,
iron oxide, [Link]:• High-density pellets5. Magnetic Systems• These systems
contain magnetic materials (e.g., iron oxide) and are controlledexternally using a magnetic field.•
Used experimentally but not widely applied due to ethical concerns patient discomfort .Example:•
Magnetic microspheres6. Raft-Forming Systems• These systems contain gel-forming agents (e.g.,
alginate, pectin, guar gum).• In the presence of gastric fluids, they form a thick, floating gel (raft) that
remains inthe stomach for localized drug action. [Link] • Antacid raft systems
10 m 3 . Here’s a detailed explanation of the applications of targeted drug delivery systems and an
in-depth discussion on monoclonal antibodies with a diagram. Targeted Drug Delivery System (TDDS)
IntroductionA targeted drug delivery system (TDDS) is a method of delivering medications directly to
specific cells or tissues, improving drug efficacy while minimizing side effects. It works by
enhancing drug concentration at the disease site while reducing exposure to healthy tissues.
Applications of Targeted Drug Delivery System1. Cancer Therapy• One of the most significant
applications of TDDS is in chemotherapy, where drugs aredelivered specifically to cancer cells.•
Mechanism:o Nanoparticles, liposomes, or monoclonal antibodies are used to deliver.
chemotherapeutic drugs to tumor cells.o This reduces damage to normal tissues and improves the
therapeutic effect.• Example:o Doxil (Liposomal Doxorubicin) – a targeted therapy for ovarian and
breastcancer. 2. Neurological Disorders (Blood-Brain Barrier Targeting)• The blood-brain barrier
(BBB) prevents many drugs from reaching the brain.• TDDS overcomes this issue by using
nanocarriers, liposomes, or antibody-based targeting.• Applications:o Treatment of Alzheimer’s,
Parkinson’s, and brain tumors.• Example:o Glutathione-coated nanoparticles allow drugs to cross the
BBB for Parkinson’s treatment.3. Autoimmune Diseases (Immunotherapy Applications)
• Targeted delivery of immunosuppressants prevents unnecessary immune
suppression throughout the body.• Used for treating rheumatoid arthritis, multiple sclerosis, and
lupus.• Example:o Adalimumab (Humira) – A monoclonal antibody that inhibits TNF-α,
reducinginflammation in autoimmune disorders.4. Cardiovascular Diseases (Targeted Thrombolytic
Therapy)• TDDS is used to deliver clot-dissolving drugs (thrombolytics) directly to the clot,reducing
the risk of internal bleeding. Example:o Tissue Plasminogen Activator (tPA) – Used in stroke patients
to dissolve blood clots selectively.5. Diabetes Management• TDDS is used to deliver insulin in a
glucose-responsive manner, improving blood sugar control.• Example:o Smart insulin patches release
insulin only when blood sugar levels are high,preventing hypoglycemia.6. Gene Therapy (Targeted
Delivery of DNA and RNA-based Drugs)• Used in gene editing (CRISPR-Cas9), siRNA therapy, and
mRNA vaccines.• Example:o mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna) deliver
geneticmaterial into cells for immune response.7. Infectious Diseases (Targeted Antimicrobial
Therapy)• TDDS can deliver antibiotics directly to infected tissues, reducing antibiotic resistance.
• Example:o Liposome-encapsulated Amphotericin B for targeted fungal infectiontreatment.
Monoclonal Antibodies (mAbs)DefinitionMonoclonal antibodies (mAbs) are artificially produced
antibodies that specifically bind to a single antigen, making them highly useful for therapeutics,
diagnostics, and targeted drugdelivery. Structure of Monoclonal AntibodiesMonoclonal antibodies
are Y-shaped glycoproteins made up of:• Two heavy chains (H-chains)• Two light chains (L-chains)
• Fab region (Antigen-binding site)• Fc region (Binds to immune cells, activating the immune
response)Production of Monoclonal Antibodies (Hybridoma Technology)1. Antigen Injection – A
mouse is injected with a specific antigen to stimulate an immune response.2. B-Cell Isolation – B
lymphocytes (producing antibodies) are extracted from thespleen.3. Fusion with Myeloma Cells – B-
cells are fused with immortal myeloma cells, forming hybridoma cells.4. Hybridoma Selection – Only
hybridoma cells survive in the HAT medium.5. Cloning & Screening – Hybridomas producing the
desired antibody are selected.6. Antibody Production & Purification – Large-scale mAb production
occurs in cell cultures or [Link] of Monoclonal Antibodies1. Cancer Therapy o
Trastuzumab (Herceptin®) – Treats breast cancer (HER2-positive).o Rituximab (Rituxan®) – Used for
lymphomas and leukemias.2. Autoimmune Diseaseso Infliximab (Remicade®) – Treats rheumatoid
arthritis, Crohn’s disease.o Adalimumab (Humira®) – Targets TNF-α to treat autoimmune disorders.
3. Viral Infectionso Palivizumab – Prevents respiratory syncytial virus (RSV) infection.o Casirivimab &
Imdevimab – Used for COVID-19 treatment.4. Diagnostic Applicationso Used in ELISA, Western Blot,
and Immunohistochemistry (IHC) for detectingcancer markers, pathogens, and proteins.

5 m 1 medication is stored and delivered.1. Dry Powder Inhalers (DPI)?A Dry Powder Inhaler (DPI) is
a breath-actuated inhaler that delivers medication in the formof a dry powder. The medication is
stored in either capsules, blister packs, or reservoirsinside the inhaler. The user must inhale deeply to
disperse and transport the powderedmedication into their [Link] Work• When the patient
inhales, airflow through the inhaler breaks up the powder into fine particles.• The particles are
carried into the lungs, where they act on the airways.• Since the inhaler is breath-actuated, the user
must inhale strongly to ensure properdrug delivery. Key Features of DPI:No propellant – Uses only
the patient’s inhalation [Link]-actuated – No pressing or coordination required
Environmentally friendly – No hydrofluoroalkane (HFA) [Link] stable medication formulation
compared to [Link] of DPI:✔ No hand-breath coordination needed.✔ Portable and easy
to carry. ✔ No need for a spacer. ✔ Propellant-free, making it environmentally [Link] of
DPI:✖ Requires strong inhalation – not suitable for elderly patients or those with weak
lungfunction.✖ Sensitive to humidity – powder may clump and affect drug delivery.✖ More
expensive than [Link] of DPI Devices: • DiskusB• Turbuhaler • Handihaler• Rotahaler2.
Metered Dose Inhalers (MDI)A Metered Dose Inhaler (MDI) is a pressurized inhaler that delivers a
measured dose ofmedication in aerosol (mist) form. The medication is stored in a pressurized
canister with apropellant that helps release the drug when the canister is [Link] Does an MDI
Work?1. Shake the inhaler to mix the medication properly.2. Press the canister while inhaling deeply
to deliver the drug into the lungs.3. Hold breath for a few seconds to allow absorption of the
medication.4. Exhale slowly after [Link] Features of MDI:Uses hydrofluoroalkane (HFA) or
other [Link] pressing the canister and inhaling at the same [Link] medication
as a fine mist (aerosol).Advantages of MDI:✔ Delivers a precise dose of medication.✔ Effective even
for patients with weak inhalation strength.✔ Compact and portable.✔ Works well with a spacer for
better drug [Link] of MDI:✖ Requires hand-breath coordination (press-inhale
timing is important).✖ Some medication may deposit in the mouth or throat if not used properly.✖
Propellants can be harmful to the environment, although modern inhalers use eco-friendly
[Link] in MDIA spacer is an attachment that helps patients use an MDI effectively. It holds the
medicationfor a short time, allowing the user to inhale more slowly and deeply, improving
drugdelivery to the lungs and reducing medication loss in the mouth or [Link] of MDI
Devices:• Ventolin HFA (Salbutamol)• ProAir HFA• Flovent HFA

5m 2. Gastro-Retentive Drug Delivery System (GRDDS) is a specialized drug delivery approach

designed to prolong the retention time of drugs in the stomach for better absorption and
therapeutic effectiveness. This system is particularly useful for drugs that have narrow
absorption windows in the upper gastrointestinal tract (stomach and small intestine) and
those that are poorly soluble in intestinal [Link] of GRDDSProlonged Gastric Retention:
Enhances drug absorption by maintaining the drug in the stomach for an extended period.
Improved Bioavailability: Beneficial for drugs that are absorbed mainly in the stomach
or upper intestine. Reduced Dosing Frequency: Sustained drug release reduces the need for
frequent dosing, improving patient compliance. Minimized Side Effects: Controlled drug release
lowers the risk of dose-related sideeffects. .Better for Local Stomach Treatment: Useful for drugs
that act locally in the stomach. Enhanced Drug Solubility: Suitable for drugs with pH-dependent
solubility, whichdissolve better in the acidic environment of the [Link] of GRDDS
✖ Not Suitable for All Drugs: Ineffective for drugs that are absorbed in the lower intestine or
colon.✖ Variability in Gastric Emptying Time: Gastric retention time may vary due to factors like
age, food intake, and gastrointestinal motility.✖ Risk of Dose Dumping: Uncontrolled drug release
due to formulation failure may lead tohigh drug concentrations, causing toxicity.✖ Formulation
Complexity: Requires advanced technologies and materials, making thedevelopment and
manufacturing process costly.✖ Potential for Irritation: Some drugs may irritate the gastric mucosa if
retained in thestomach for a long time.
5 m 3 [Link] of Preparation of LiposomesLiposomes are spherical vesicles composed of
phospholipid bilayers that can encapsulateboth hydrophilic and lipophilic drugs. They are widely
used in drug delivery, gene therapy,and cosmetics. Various methods exist for preparing liposomes,
depending on the desiredsize, lamellarity (number of bilayers), and drug encapsulation efficiency.
1. Thin Film Hydration Method (Bangham Method)Principle:Lipids are dissolved in an organic solvent,
evaporated to form a thin film, and then hydratedwith an aqueous [Link]. Dissolve
phospholipids (e.g., phosphatidylcholine) and cholesterol in a volatileorganic solvent (chloroform,
methanol).2. Evaporate the solvent using a rotary evaporator to form a thin lipid film on the wall
of the flask.3. Hydrate the lipid film by adding a warm aqueous buffer and vortexing/mixing to
form multilamellar vesicles (MLVs).4. Reduce the vesicle size using sonication or extrusion if needed.
Advantages:✔ Simple and widely used.✔ Suitable for hydrophilic and lipophilic drugs.
Disadvantages:✖ Heterogeneous vesicle size.✖ Low encapsulation efficiency for hydrophilic drugs.
2. Sonication MethodPrinciple ound waves (ultrasound) are used to break multilamellar vesicles
(MLVs) into smaller unilamellar vesicles (SUVs). Steps:1. Prepare MLVs using the thin film hydration
method.2. Expose the MLVs to ultrasonic waves using a probe-type or bath-type sonicator.
3. The process reduces the size and forms small unilamellar vesicles (SUVs).Advantages:✔ Produces
small, uniform vesicles.✔ Simple and [Link]:✖ High temperature may degrade
sensitive drugs.✖ Possible contamination from the probe. 3. Extrusion Method
Principle:Liposomes are forced through a membrane filter with small pores to control their size.
Steps:1. Prepare MLVs using the thin film hydration method.2. Pass the liposome suspension through
a polycarbonate membrane filter withdefined pore sizes using high pressure.3. Repeat the process
multiple times to obtain uniform-sized liposomes. Advantages:✔ Produces highly uniform liposomes.
.Disadvantages:✖ Requires specialized equipment. B4. Reverse Phase Evaporation Method
(RPEV)Principle:Lipids are dissolved in an organic phase and then mixed with an aqueous phase to
form an emulsion, followed by solvent removal to form [Link]. Dissolve lipids in an
organic solvent (chloroform, ether).2. Add an aqueous phase (containing the drug) and sonicate to
form a water-in-oil(W/O) emulsion.3. Remove the organic solvent by slow evaporation under
reduced pressure.4. The remaining lipid film spontaneously forms liposomes upon
[Link]:✔ High encapsulation efficiency for hydrophilic drugs Disadvantages:✖
Residual organic solvent may be toxic. 5. Detergent Removal Method (Dialysis
Method )LPrinciple:Lipids and drugs are solubilized in a detergent solution, and the detergent is then
bremovedslowly to form [Link]. Dissolve lipids and drugs in a solution containing a
detergent (e.g., Triton X-100).2. Slowly remove the detergent using dialysis or gel filtration.3.
Liposomes form as the detergent concentration [Link]:✔ Produces small unilamellar
vesicles (SUVs).Disadvantages:✖ Detergent removal can be slow

2 m Surfactant used in niosomes

Niosomes are prepared using a variety of non-ionic surfactants like Tweens (e.g., Tween 20, 40, 60,
80), Spans (e.g., Span 20, 40, 60, 80, 85), and Brij (e.g., Brij 30, 35, 52, 58, 72, 76)

…
5m 4 Applications of Transdermal Drug Delivery System1. Pain Management (Analgesic Patches)
TDDS is widely used for delivering pain-relieving medications over an extended period.• Advantages:
o Continuous pain relief without frequent dosing.• Examples:o Fentanyl Patch (Duragesic) – Used for
chronic pain management, especially inc ancer patients.o Lidocaine Patch (Lidoderm) – Provides
localized pain relief for conditions likepost-herpetic neuralgia. 2. Hormone Replacement Therapy
(HRT) & Contraception Hormones are often administered through transdermal patches to maintain
stable hormone levels in the body.• Advantages: o Avoids fluctuations in hormone levels seen with
oral pills.• Examples:o Estradiol Patch (Climara, Vivelle-Dot) – Used in menopause for estrogen
replacement. 3. Nicotine Replacement Therapy (Smoking Cessation Patches)TDDS is used to deliver
nicotine in a controlled manner to help people quit smoking.• Advantages:o Reduces withdrawal
symptoms by providing a steady dose of nicotine.• Examples:o Nicotine Patch (Nicoderm, Nicorette)
– Helps smokers reduce dependence oncigarettes. 4. Cardiovascular Disease Treatment (Anti-
Hypertensive & Anti-Anginal Patches)TDDS is used for the long-term treatment of heart diseases
such as hypertension and angina.• Advantages:o Ensures a steady drug release, preventing sudden
blood pressure fluctuations.• Examples:o Nitroglycerin Patch (Minitran, Nitro-Dur) – Used for angina
(heart pain)prevention. 5. Neurological Disorders (Alzheimer’s & Parkinson’s Disease Patches)
Transdermal patches help deliver drugs for neurological diseases, ensuring a continuous
drug supply to the brain.• Advantages:o Avoids fluctuations in drug levels, improving patient
outcomes.• Examples: Rivastigmine Patch (Exelon) – Used to manage Alzheimer’s disease.
o Rotigotine Patch (Neupro) – Used for Parkinson’s disease and restless leg syndrome. 6. Migraine
Treatment (Triptan Patches) TDDS provides fast relief from migraine attacks without the need for
injections.• Examples:o Sumatriptan Patch (Zecuity) – Used for acute migraine relief.
7. Osteoporosis Treatment Transdermal patches are used to deliver osteoporosis medications for
postmenopausalwomen.• Examples:o Parathyroid Hormone Patch (PTH 1-34) – Used to treat
osteoporosis. 8. Motion Sickness & Nausea ReliefTDDS allows continuous drug absorption to
prevent nausea and motion sickness.• Examples:o Scopolamine Patch (Transderm Scop) – Used to
prevent motion sickness and nausea after surgery. 9. ADHD Treatment (Attention Deficit
Hyperactivity Disorder10. Anti-Inflammatory and Arthritis Treatment